Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Langsheng Pharmaceutical is a prominent Chinese pharmaceutical company specializing in reproductive health, dermatology, and male health. Founded in 2003, the company is best known for its flagship emergency contraceptive brand, Yuting (levonorgestrel), which holds a significant share of the Chinese market. Langsheng operates integrated R&D, manufacturing, and commercialization facilities, focusing on high-barrier generic drugs and innovative formulations. Beyond contraception, the company has expanded its portfolio into treatments for erectile dysfunction and various dermatological conditions. It is recognized as a High-Tech Enterprise in China with a strong emphasis on intellectual property and quality-driven manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Langsheng Pharmaceutical.